| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripherins | 36 | 2023 | 47 | 5.690 |
Why?
|
| Retinal Degeneration | 23 | 2023 | 141 | 3.630 |
Why?
|
| Retinal Cone Photoreceptor Cells | 22 | 2023 | 115 | 3.380 |
Why?
|
| Eye Proteins | 26 | 2023 | 197 | 2.810 |
Why?
|
| Genetic Therapy | 18 | 2016 | 116 | 2.550 |
Why?
|
| Nerve Tissue Proteins | 15 | 2019 | 151 | 2.360 |
Why?
|
| Intermediate Filament Proteins | 13 | 2012 | 21 | 2.280 |
Why?
|
| Membrane Glycoproteins | 14 | 2019 | 143 | 2.260 |
Why?
|
| Tetraspanins | 20 | 2023 | 36 | 2.160 |
Why?
|
| Electroretinography | 13 | 2024 | 173 | 2.120 |
Why?
|
| Retinitis Pigmentosa | 10 | 2023 | 28 | 1.870 |
Why?
|
| Macular Degeneration | 8 | 2023 | 79 | 1.830 |
Why?
|
| Retina | 17 | 2024 | 421 | 1.830 |
Why?
|
| Retinal Diseases | 9 | 2022 | 45 | 1.780 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 7 | 2020 | 18 | 1.640 |
Why?
|
| Retinal Rod Photoreceptor Cells | 15 | 2019 | 90 | 1.430 |
Why?
|
| Aging | 6 | 2024 | 960 | 1.400 |
Why?
|
| Membrane Proteins | 12 | 2019 | 470 | 1.360 |
Why?
|
| Mutation | 16 | 2023 | 823 | 1.360 |
Why?
|
| Nanoparticles | 16 | 2018 | 276 | 1.300 |
Why?
|
| Mice | 50 | 2024 | 4472 | 1.280 |
Why?
|
| DNA | 15 | 2018 | 365 | 1.230 |
Why?
|
| Animals | 65 | 2024 | 10082 | 1.220 |
Why?
|
| Photoreceptor Cells, Vertebrate | 8 | 2020 | 62 | 1.040 |
Why?
|
| Mice, Inbred C57BL | 12 | 2024 | 1496 | 1.020 |
Why?
|
| Rhodopsin | 5 | 2020 | 40 | 0.940 |
Why?
|
| Amino Acid Substitution | 5 | 2019 | 102 | 0.910 |
Why?
|
| Cognitive Dysfunction | 3 | 2023 | 268 | 0.900 |
Why?
|
| Fasting | 1 | 2024 | 80 | 0.880 |
Why?
|
| Phenotype | 9 | 2022 | 667 | 0.880 |
Why?
|
| Rod Cell Outer Segment | 4 | 2019 | 42 | 0.850 |
Why?
|
| Cone Opsins | 2 | 2014 | 6 | 0.840 |
Why?
|
| Dementia, Vascular | 2 | 2023 | 60 | 0.820 |
Why?
|
| Retinal Vessels | 3 | 2021 | 71 | 0.780 |
Why?
|
| Photoreceptor Cells | 5 | 2023 | 36 | 0.780 |
Why?
|
| Microcirculation | 3 | 2021 | 112 | 0.720 |
Why?
|
| Eye Diseases, Hereditary | 3 | 2016 | 6 | 0.690 |
Why?
|
| Humans | 48 | 2023 | 27175 | 0.670 |
Why?
|
| Wet Macular Degeneration | 1 | 2019 | 9 | 0.670 |
Why?
|
| Choroid | 1 | 2019 | 20 | 0.660 |
Why?
|
| Gene Expression Regulation | 9 | 2020 | 627 | 0.650 |
Why?
|
| Genetic Vectors | 6 | 2016 | 107 | 0.640 |
Why?
|
| Gene Transfer Techniques | 8 | 2015 | 66 | 0.630 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 163 | 0.620 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2014 | 35 | 0.590 |
Why?
|
| Mice, Transgenic | 13 | 2020 | 490 | 0.580 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 3 | 2016 | 54 | 0.570 |
Why?
|
| Trabecular Meshwork | 4 | 2008 | 16 | 0.550 |
Why?
|
| Protein Transport | 8 | 2020 | 153 | 0.550 |
Why?
|
| Eye Diseases | 3 | 2016 | 31 | 0.550 |
Why?
|
| Retinal Pigment Epithelium | 9 | 2022 | 90 | 0.550 |
Why?
|
| Night Blindness | 1 | 2016 | 1 | 0.510 |
Why?
|
| RNA, Catalytic | 1 | 2016 | 8 | 0.510 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2016 | 7 | 0.510 |
Why?
|
| Myopia | 1 | 2016 | 18 | 0.510 |
Why?
|
| Protein Multimerization | 7 | 2019 | 53 | 0.500 |
Why?
|
| Disease Models, Animal | 17 | 2020 | 1406 | 0.500 |
Why?
|
| Mice, Knockout | 13 | 2023 | 793 | 0.480 |
Why?
|
| Morphogenesis | 4 | 2019 | 21 | 0.450 |
Why?
|
| Antigens, CD | 1 | 2014 | 134 | 0.430 |
Why?
|
| Glycoproteins | 1 | 2014 | 120 | 0.430 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 110 | 0.410 |
Why?
|
| Gene Knock-In Techniques | 5 | 2019 | 18 | 0.390 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2012 | 1 | 0.390 |
Why?
|
| Transducin | 1 | 2012 | 13 | 0.390 |
Why?
|
| Pyridinium Compounds | 1 | 2011 | 9 | 0.380 |
Why?
|
| Peptides | 1 | 2014 | 283 | 0.380 |
Why?
|
| Retinoids | 1 | 2011 | 37 | 0.380 |
Why?
|
| Codon | 2 | 2016 | 22 | 0.370 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 5 | 2014 | 31 | 0.370 |
Why?
|
| cis-trans-Isomerases | 4 | 2014 | 25 | 0.340 |
Why?
|
| RNA | 3 | 2016 | 106 | 0.340 |
Why?
|
| Protein Subunits | 1 | 2010 | 40 | 0.330 |
Why?
|
| Dependovirus | 3 | 2016 | 9 | 0.320 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2023 | 291 | 0.310 |
Why?
|
| Genetic Variation | 1 | 2010 | 229 | 0.310 |
Why?
|
| Qa-SNARE Proteins | 2 | 2020 | 7 | 0.300 |
Why?
|
| Point Mutation | 1 | 2007 | 60 | 0.290 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2005 | 40 | 0.280 |
Why?
|
| Transgenes | 7 | 2012 | 59 | 0.280 |
Why?
|
| Homeostasis | 2 | 2020 | 114 | 0.280 |
Why?
|
| Antioxidants | 3 | 2016 | 223 | 0.270 |
Why?
|
| Plasmids | 5 | 2018 | 121 | 0.250 |
Why?
|
| Selenium | 1 | 2005 | 17 | 0.250 |
Why?
|
| Disease Progression | 2 | 2019 | 458 | 0.240 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 11 | 0.220 |
Why?
|
| Organoselenium Compounds | 1 | 2004 | 8 | 0.220 |
Why?
|
| Carboxylic Acids | 1 | 2004 | 17 | 0.220 |
Why?
|
| Male | 10 | 2024 | 13034 | 0.220 |
Why?
|
| Aged | 7 | 2023 | 5232 | 0.220 |
Why?
|
| Caloric Restriction | 1 | 2024 | 73 | 0.220 |
Why?
|
| Mutant Proteins | 2 | 2016 | 25 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 333 | 0.210 |
Why?
|
| Metal Nanoparticles | 2 | 2016 | 128 | 0.210 |
Why?
|
| Brain | 4 | 2023 | 710 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 101 | 0.210 |
Why?
|
| Dark Adaptation | 2 | 2014 | 11 | 0.210 |
Why?
|
| Atrophy | 1 | 2022 | 14 | 0.200 |
Why?
|
| Scotoma | 1 | 2022 | 6 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 229 | 0.200 |
Why?
|
| Parabiosis | 1 | 2022 | 17 | 0.190 |
Why?
|
| Heterozygote | 2 | 2019 | 64 | 0.190 |
Why?
|
| Mutation, Missense | 2 | 2019 | 68 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 666 | 0.190 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 89 | 0.190 |
Why?
|
| Photic Stimulation | 2 | 2019 | 67 | 0.190 |
Why?
|
| Blotting, Western | 5 | 2015 | 506 | 0.190 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 37 | 0.180 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 220 | 0.180 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 9 | 0.180 |
Why?
|
| Retinal Photoreceptor Cell Inner Segment | 1 | 2020 | 4 | 0.180 |
Why?
|
| Cone-Rod Dystrophies | 1 | 2020 | 1 | 0.170 |
Why?
|
| Vision, Ocular | 2 | 2011 | 27 | 0.170 |
Why?
|
| Blindness | 2 | 2011 | 34 | 0.170 |
Why?
|
| Transcriptome | 1 | 2022 | 205 | 0.170 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 66 | 0.160 |
Why?
|
| Retinal Artery | 1 | 2019 | 10 | 0.160 |
Why?
|
| Multiprotein Complexes | 2 | 2017 | 53 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2020 | 80 | 0.160 |
Why?
|
| Visual Perception | 1 | 2019 | 44 | 0.160 |
Why?
|
| Cerebral Arteries | 1 | 2019 | 33 | 0.160 |
Why?
|
| Vasodilation | 1 | 2019 | 114 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 6 | 2018 | 100 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 209 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 1 | 2019 | 90 | 0.150 |
Why?
|
| Eye | 1 | 2018 | 35 | 0.150 |
Why?
|
| Free Radical Scavengers | 2 | 2016 | 23 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 91 | 0.140 |
Why?
|
| Gene Expression | 6 | 2014 | 407 | 0.140 |
Why?
|
| Matrix Attachment Regions | 2 | 2014 | 2 | 0.140 |
Why?
|
| Neurovascular Coupling | 1 | 2019 | 154 | 0.140 |
Why?
|
| Pedigree | 1 | 2017 | 154 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 77 | 0.130 |
Why?
|
| Transduction, Genetic | 3 | 2012 | 24 | 0.130 |
Why?
|
| Hypertension | 1 | 2019 | 304 | 0.130 |
Why?
|
| Biocatalysis | 1 | 2016 | 22 | 0.130 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 21 | 0.130 |
Why?
|
| Analysis of Variance | 3 | 2012 | 388 | 0.130 |
Why?
|
| Substrate Specificity | 1 | 2016 | 150 | 0.120 |
Why?
|
| Biomarkers | 2 | 2020 | 736 | 0.120 |
Why?
|
| Transfection | 4 | 2013 | 313 | 0.120 |
Why?
|
| Lipofuscin | 2 | 2012 | 7 | 0.120 |
Why?
|
| Female | 8 | 2020 | 14658 | 0.120 |
Why?
|
| Nanomedicine | 1 | 2016 | 62 | 0.120 |
Why?
|
| Yttrium | 1 | 2014 | 2 | 0.120 |
Why?
|
| Biolistics | 1 | 2014 | 1 | 0.110 |
Why?
|
| Genes, Synthetic | 1 | 2014 | 4 | 0.110 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2014 | 32 | 0.110 |
Why?
|
| Retinol-Binding Proteins | 1 | 2014 | 6 | 0.110 |
Why?
|
| AC133 Antigen | 1 | 2014 | 7 | 0.110 |
Why?
|
| Fundus Oculi | 1 | 2014 | 15 | 0.110 |
Why?
|
| Protein Binding | 3 | 2012 | 636 | 0.110 |
Why?
|
| Color Vision | 1 | 2014 | 3 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 400 | 0.110 |
Why?
|
| Tryptophan | 1 | 2014 | 38 | 0.110 |
Why?
|
| Lentivirus | 1 | 2014 | 16 | 0.110 |
Why?
|
| Incidence | 2 | 2013 | 553 | 0.110 |
Why?
|
| Arginine | 1 | 2014 | 39 | 0.110 |
Why?
|
| Global Health | 1 | 2013 | 43 | 0.110 |
Why?
|
| Chitosan | 1 | 2013 | 31 | 0.110 |
Why?
|
| Nanotechnology | 2 | 2013 | 67 | 0.100 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2013 | 5 | 0.100 |
Why?
|
| Retinal Neovascularization | 1 | 2013 | 20 | 0.100 |
Why?
|
| Vision Disorders | 1 | 2013 | 38 | 0.100 |
Why?
|
| Glycomics | 1 | 2012 | 2 | 0.100 |
Why?
|
| Heparitin Sulfate | 1 | 2012 | 14 | 0.100 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2012 | 4 | 0.100 |
Why?
|
| Membranes | 1 | 2012 | 8 | 0.100 |
Why?
|
| Genes, p53 | 1 | 2012 | 14 | 0.100 |
Why?
|
| Polysaccharides | 1 | 2012 | 61 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 94 | 0.100 |
Why?
|
| Retinaldehyde | 1 | 2011 | 7 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 94 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2010 | 50 | 0.090 |
Why?
|
| Models, Molecular | 2 | 2012 | 445 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 99 | 0.090 |
Why?
|
| Software | 1 | 2012 | 121 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2011 | 33 | 0.090 |
Why?
|
| Diabetic Retinopathy | 1 | 2013 | 108 | 0.090 |
Why?
|
| Insulin | 1 | 2013 | 314 | 0.090 |
Why?
|
| Cell Line | 2 | 2018 | 681 | 0.090 |
Why?
|
| Asparagine | 1 | 2010 | 7 | 0.090 |
Why?
|
| COS Cells | 1 | 2010 | 48 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2012 | 155 | 0.080 |
Why?
|
| Histidine | 1 | 2010 | 50 | 0.080 |
Why?
|
| Nanocomposites | 1 | 2009 | 12 | 0.080 |
Why?
|
| Lysine | 1 | 2010 | 71 | 0.080 |
Why?
|
| Mitosis | 1 | 2009 | 109 | 0.080 |
Why?
|
| Phylogeny | 1 | 2011 | 463 | 0.080 |
Why?
|
| Aquaporin 1 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Aqueous Humor | 1 | 2008 | 24 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 264 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 10 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 324 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2009 | 246 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 217 | 0.070 |
Why?
|
| Intravitreal Injections | 2 | 2018 | 33 | 0.070 |
Why?
|
| Opsins | 3 | 2010 | 18 | 0.060 |
Why?
|
| Trace Elements | 1 | 2005 | 8 | 0.060 |
Why?
|
| Integrins | 1 | 2005 | 27 | 0.060 |
Why?
|
| Manganese | 1 | 2005 | 22 | 0.060 |
Why?
|
| Umbilical Veins | 1 | 2005 | 25 | 0.060 |
Why?
|
| Time Factors | 2 | 2009 | 1573 | 0.060 |
Why?
|
| Oxidative Stress | 3 | 2016 | 630 | 0.060 |
Why?
|
| Middle Aged | 4 | 2019 | 6918 | 0.060 |
Why?
|
| Infant | 2 | 2005 | 971 | 0.060 |
Why?
|
| Zinc | 1 | 2005 | 59 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2015 | 1374 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 93 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2004 | 8 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2005 | 977 | 0.060 |
Why?
|
| Fires | 1 | 2004 | 10 | 0.060 |
Why?
|
| Adult | 4 | 2019 | 7510 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2004 | 67 | 0.060 |
Why?
|
| Glycosylation | 2 | 2015 | 69 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 23 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 22 | 0.060 |
Why?
|
| Cell Survival | 1 | 2005 | 395 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 163 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 62 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2016 | 283 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 84 | 0.050 |
Why?
|
| Reference Values | 2 | 2019 | 199 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 280 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 188 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2005 | 340 | 0.050 |
Why?
|
| Light | 2 | 2014 | 117 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2004 | 567 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 591 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 40 | 0.050 |
Why?
|
| Cytokines | 2 | 2018 | 440 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 110 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 864 | 0.050 |
Why?
|
| SNARE Proteins | 1 | 2020 | 6 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2020 | 32 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2020 | 16 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 131 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 116 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 128 | 0.040 |
Why?
|
| Bromodeoxyuridine | 2 | 2012 | 9 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 455 | 0.040 |
Why?
|
| Arterioles | 1 | 2019 | 61 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2019 | 54 | 0.040 |
Why?
|
| Apoptosis | 2 | 2013 | 738 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 24 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2018 | 14 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 762 | 0.040 |
Why?
|
| Primates | 1 | 2018 | 22 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 154 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2016 | 65 | 0.030 |
Why?
|
| Lanthanoid Series Elements | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 58 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 83 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 26 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 110 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2015 | 135 | 0.030 |
Why?
|
| Papio anubis | 1 | 2014 | 40 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 128 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2013 | 4 | 0.030 |
Why?
|
| Bestrophins | 1 | 2013 | 5 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 115 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 177 | 0.030 |
Why?
|
| Maltose-Binding Proteins | 1 | 2012 | 6 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2012 | 43 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 2012 | 2 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 81 | 0.030 |
Why?
|
| Protein Stability | 1 | 2012 | 42 | 0.030 |
Why?
|
| Injections, Intraocular | 1 | 2012 | 5 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 66 | 0.030 |
Why?
|
| Action Potentials | 1 | 2013 | 193 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 752 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 75 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 137 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2012 | 2 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 9 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 42 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 2636 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 122 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 121 | 0.020 |
Why?
|
| Cattle | 1 | 2012 | 383 | 0.020 |
Why?
|
| Light Signal Transduction | 1 | 2010 | 8 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2010 | 35 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2010 | 2 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 5 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 2010 | 7 | 0.020 |
Why?
|
| Retinal Neoplasms | 1 | 2010 | 8 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 26 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 329 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 205 | 0.020 |
Why?
|
| Viruses | 1 | 2010 | 18 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 32 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 310 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 342 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2009 | 56 | 0.020 |
Why?
|
| Disulfides | 1 | 2008 | 33 | 0.020 |
Why?
|
| Anterior Eye Segment | 1 | 2008 | 4 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2009 | 110 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 244 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 55 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 506 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 190 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2008 | 66 | 0.020 |
Why?
|
| Macrophages | 1 | 2009 | 281 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 514 | 0.020 |
Why?
|
| Aurintricarboxylic Acid | 1 | 2005 | 1 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2005 | 10 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2005 | 15 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cell Division | 1 | 2005 | 154 | 0.020 |
Why?
|
| DNA Replication | 1 | 2005 | 49 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 605 | 0.020 |
Why?
|
| Occupational Health | 1 | 2004 | 10 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2004 | 16 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2004 | 26 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 75 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 93 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 262 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 575 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 1943 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 708 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1041 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 597 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 990 | 0.010 |
Why?
|